Related Experiment Video
Updated: Mar 24, 2026

08:46
Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
Published on: May 18, 2016
18.5K
Interleukin-27-Producing CD4(+) T Cells Regulate Protective Immunity during Malaria Parasite Infection
Daisuke Kimura1, Mana Miyakoda1, Kazumi Kimura1
1Division of Immunology, Department of Molecular Microbiology and Immunology, Graduate School of Biomedical Sciences, Nagasaki University, 1-12-4, Sakamoto, Nagasaki, 852-8523 Japan.
Immunity
|March 13, 2016
Summary
Regulatory CD4(+) T cells producing Interleukin-27 (IL-27) were identified during malaria infection. These cells inhibit T cell expansion, and their absence improves immunity and reduces parasite burden.
Area of Science:
- Immunology
- Infectious Diseases
- Cytokine Biology
Background:
- Interleukin-27 (IL-27) is a cytokine in the IL-12 family, typically produced by innate immune cells.
- Regulatory T cells play a crucial role in modulating immune responses during infections.
Purpose of the Study:
- To identify and characterize novel regulatory CD4(+) T cells involved in malaria infection.
- To investigate the role of IL-27 produced by T cells in regulating immune responses during malaria.
Main Methods:
- Analysis of malaria-specific CD4(+) T cells.
- Detection of IL-27 production by T cells.
- Assessment of T cell proliferation and cytokine production (IL-2, IFN-γ).
- Studies in mice lacking IL-27 in T cells.
Main Results:
- A distinct population of Foxp3(-)CD11a(+)CD49d(+) regulatory CD4(+) T cells producing IL-27 was identified during malaria.
- These IL-27-producing T cells suppressed IL-2 production and clonal expansion of other T cells in an IL-27-dependent manner.
- In mice lacking T cell-derived IL-27, IL-2 production and CD4(+) T cell expansion/IFN-γ production were enhanced, leading to reduced parasite burden.
Conclusions:
- A unique subset of IL-27-producing regulatory CD4(+) T cells actively suppresses anti-malarial T cell responses.
- Targeting these regulatory T cells or their IL-27 production could be a therapeutic strategy to enhance protective immunity against malaria.

